Moderna, Inc. (MRNA) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Moderna, Inc. (MRNA) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

MRNA Income Statement

Moderna, Inc. (MRNA) annual income statement — 10-year revenue, gross profit & net income history

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Sales/Revenue	145M	389M	678M	1.02B	142M	107M	956M	1.85B	221M	167M	2.81B	1.83B	344M	1.84B	5.15B	3.22B	4.57B	5.94B	6.95B	4.83B
Revenue Growth %	2.11%	263.55%	-29.08%	-45.23%	-35.75%	-35.93%	-66.01%	1.31%	-35.76%	-90.91%	-45.37%	-43.14%	-92.47%	-69.06%	-25.9%	-33.32%	8.33%	240.79%	1117.53%	2958.07%
Cost of Goods Sold	93M	955M	452M	1.01B	119M	90M	739M	514M	115M	96M	929M	2.24B	731M	792M	1.92B	1.1B	1.38B	1.02B	952M	722M
COGS % of Revenue	64.14%	245.5%	66.67%	99.21%	83.8%	84.11%	77.3%	27.71%	52.04%	57.48%	33.03%	122.39%	212.5%	43.09%	37.25%	34.16%	30.25%	17.12%	13.7%	14.95%
Gross Profit	52M	-566M	226M	8M	23M	17M	217M	1.34B	106M	71M	1.88B	-410M	-387M	1.05B	3.23B	2.12B	3.19B	4.92B	6B	4.11B
Gross Margin %	35.86%	-145.5%	33.33%	0.79%	16.2%	15.89%	22.7%	72.29%	47.96%	42.52%	66.97%	-22.39%	-112.5%	56.91%	62.75%	65.84%	69.75%	82.88%	86.3%	85.05%
Gross Profit Growth %	126.09%	-3429.41%	4.15%	-99.4%	-78.3%	-76.06%	-88.48%	427.07%	127.39%	-93.21%	-41.69%	-119.34%	-112.15%	-78.75%	-46.12%	-48.38%	-8.08%	217.61%	980.33%	2648.81%
Operating Expenses	867M	822M	1.08B	268M	930M	1.07B	1.46B	1.41B	1.47B	1.34B	1.88B	1.6B	1.48B	1.41B	1.65B	954M	738M	696M	587M	549M
OpEx % of Revenue	597.93%	211.31%	159.73%	26.38%	654.93%	997.2%	153.03%	76.06%	664.71%	800.6%	66.76%	87.49%	430.23%	76.82%	32.06%	29.63%	16.16%	11.72%	8.45%	11.37%
Selling, General & Admin	216M	173M	308M	268M	230M	212M	351M	281M	268M	274M	470M	442M	332M	305M	375M	278M	211M	268M	201M	168M
SG&A % of Revenue	148.97%	44.47%	45.43%	26.38%	161.97%	198.13%	36.72%	15.15%	121.27%	164.07%	16.71%	24.14%	96.51%	16.59%	7.28%	8.63%	4.62%	4.51%	2.89%	3.48%
Research & Development	651M	649M	775M	801M	700M	856M	1.12B	1.14B	1.22B	1.03B	1.41B	1.16B	1.15B	1.13B	1.21B	820M	710M	554M	648M	521M
R&D % of Revenue	448.97%	166.84%	114.31%	78.84%	492.96%	800%	117.36%	61.29%	552.49%	614.97%	49.98%	63.35%	333.72%	61.53%	23.52%	25.47%	15.55%	9.33%	9.33%	10.79%
Other Operating Expenses	0	0	0	-1000K	0	-1000K	-1000K	-1000K	-1000K	1000K	1000K	0	0	-1000K	1000K	-1000K	-1000K	-1000K	-1000K	-1000K
Operating Income	-815M	-1.39B	-857M	-260M	-907M	-1.05B	-1.25B	-70M	-1.36B	-1.27B	6M	-2.01B	-1.87B	-366M	1.58B	1.17B	2.45B	4.23B	5.41B	3.56B
Operating Margin %	-562.07%	-356.81%	-126.4%	-25.59%	-638.73%	-981.31%	-130.33%	-3.77%	-616.74%	-758.08%	0.21%	-109.89%	-542.73%	-19.91%	30.69%	36.21%	53.59%	71.16%	77.85%	73.68%
Operating Income Growth %	10.14%	-32.19%	31.22%	-271.43%	33.46%	17.06%	-20866.67%	96.52%	27%	-245.9%	-99.62%	-272.56%	-176.3%	-108.66%	-70.79%	-67.23%	-20.08%	233.89%	2067%	1613.29%
EBITDA	-752M	-1.33B	-790M	-208M	-850M	-1.01B	-1.19B	-18M	-1.32B	-1.23B	208M	-1.76B	-1.78B	-288M	1.66B	1.28B	2.52B	4.31B	5.49B	3.63B
EBITDA Margin %	-518.62%	-341.65%	-116.52%	-20.47%	-598.59%	-944.86%	-124.06%	-0.97%	-598.19%	-736.53%	7.39%	-96.29%	-516.57%	-15.67%	32.24%	39.72%	55.26%	72.49%	78.98%	75.13%
EBITDA Growth %	11.53%	-31.45%	33.39%	-1055.56%	35.7%	17.8%	-670.19%	98.98%	25.61%	-327.08%	-87.47%	-237.84%	-170.43%	-106.69%	-69.75%	-64.75%	-19.42%	236.14%	2152.88%	1700.94%
D&A (Non-Cash Add-back)	63M	59M	67M	52M	57M	39M	60M	52M	41M	36M	202M	249M	90M	78M	80M	113M	76M	79M	78M	70M
EBIT	-767M	-1.32B	-799M	-187M	-817M	-963M	-1.18B	27M	-1.27B	-1.16B	76M	-1.95B	-1.74B	-296M	1.67B	1.23B	2.48B	4.24B	5.42B	3.56B
Net Interest Income	67M	55M	62M	73M	80M	89M	85M	97M	105M	114M	97M	95M	91M	100M	77M	50M	35M	9M	1M	0
Interest Income	67M	72M	70M	73M	81M	90M	91M	103M	111M	120M	103M	105M	104M	109M	87M	58M	40M	15M	7M	4M
Interest Expense	0	17M	8M	0	1M	1M	6M	6M	6M	6M	6M	10M	13M	9M	10M	8M	5M	6M	6M	4M
Other Income/Expense	48M	54M	58M	73M	89M	86M	62M	91M	84M	101M	64M	54M	118M	61M	75M	51M	27M	2M	0	-6M
Pretax Income	-767M	-1.33B	-799M	-187M	-818M	-964M	-1.18B	21M	-1.28B	-1.17B	70M	-1.96B	-1.75B	-305M	1.66B	1.22B	2.47B	4.23B	5.41B	3.55B
Pretax Margin %	-528.97%	-342.93%	-117.85%	-18.41%	-576.06%	-900.93%	-123.85%	1.13%	-578.73%	-697.6%	2.49%	-106.94%	-508.43%	-16.59%	32.14%	37.8%	54.18%	71.2%	77.85%	73.56%
Income Tax	15M	9M	27M	13M	7M	7M	-64M	8M	0	10M	-147M	1.67B	-369M	-384M	190M	174M	277M	572M	542M	219M
Effective Tax Rate %	-1.96%	-0.67%	-3.38%	-6.95%	-0.86%	-0.73%	5.41%	38.1%	0%	-0.86%	-210%	-85.39%	21.1%	125.9%	11.48%	14.3%	11.2%	13.53%	10.02%	6.17%
Net Income	-782M	-1.34B	-826M	-200M	-825M	-971M	-1.12B	13M	-1.28B	-1.18B	217M	-3.63B	-1.38B	79M	1.47B	1.04B	2.2B	3.66B	4.87B	3.33B
Net Margin %	-539.31%	-345.24%	-121.83%	-19.68%	-580.99%	-907.48%	-117.15%	0.7%	-578.73%	-703.59%	7.71%	-198.25%	-401.16%	4.3%	28.45%	32.39%	48.12%	61.57%	70.05%	69.02%
Net Income Growth %	5.21%	-38.31%	26.25%	-1638.46%	35.5%	17.36%	-616.13%	100.36%	7.32%	-1587.34%	-85.19%	-448.03%	-162.81%	-97.84%	-69.91%	-68.71%	-20.97%	199.51%	1886.52%	1526.58%
Net Income (Continuing)	-782M	-1.34B	-826M	-200M	-825M	-971M	-1.12B	13M	-1.28B	-1.18B	217M	-3.63B	-1.38B	79M	1.47B	1.04B	2.2B	3.66B	4.87B	3.33B
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-1.96	-3.40	-2.11	-0.51	-2.13	-2.52	-2.91	0.03	-3.33	-3.08	0.55	-9.53	-3.62	0.20	3.62	2.53	5.24	8.58	11.29	7.70
EPS Growth %	7.98%	-34.92%	27.49%	-1664.42%	36.04%	18.18%	-629.09%	100.34%	8.01%	-1640%	-84.81%	-476.68%	-169.08%	-97.67%	-67.94%	-67.14%	-18.89%	202.11%	1736.23%	1405.08%
EPS (Basic)	-1.96	-3.40	-2.11	-0.51	-2.13	-2.52	-2.91	0.03	-3.33	-3.08	0.57	-9.53	-3.62	0.20	3.81	2.67	5.55	9.09	12.03	8.27
Diluted Shares Outstanding	396M	395M	392M	390M	388M	386M	385M	399M	384M	382M	395M	381M	381M	405M	405M	412M	419M	426M	431M	434M
Basic Shares Outstanding	396M	395M	392M	390M	388M	386M	385M	385M	384M	382M	381M	381M	381M	386M	385M	390M	396M	402M	405M	404M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-